Essity AB stock analysis
Essity AB (ESWB) Stock Price & Analysis
ESWB Stock Chart & Stats
- Day’s Range
- EUR 26.42 - EUR 26.54
- 52-Week Range
- EUR 22.01 - EUR 27.21
- Previous Close
- EUR 25.96
- Volume
- N/A
- Average Volume (3M)
- 112
- Market Cap
- EUR 17.84B
- Enterprise Value
- EUR 208.44B
- Total Cash (Recent Filing)
- EUR 6.56B
- Total Debt (Recent Filing)
- EUR 39.24B
- Price to Earnings (P/E)
- 17.7
- Beta
- 0.37
- Next Earnings
- Jan 21, 2027 (Est.)
- EPS Estimate
- 0.42
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 2.77%
Bulls Say, Bears Say
Bulls Say
Personal Care Market Share
Share gains across branded Incontinence Care, Feminine Care and other Personal Care categories indicate stronger consumer and channel positioning. Because the gains translated into higher volume and sales, they support durable growth potential and better utilization of Essity’s established brands.
Balance Sheet Strength
Low net debt relative to EBITDA gives Essity meaningful financial flexibility while it funds acquisitions, innovation, dividends and restructuring. The stronger capital structure should improve resilience through cost volatility and preserve capacity for strategic investment over the next several quarters.
Cash Generation
Essity is generating positive and recently improving operating and free cash flow, providing internal funding for investment, shareholder distributions and debt management. Although conversion is moderate, the latest rebound supports the company’s ability to execute its strategy without relying heavily on external capital.
Bears Say
Weak Organic Growth
Negative organic growth shows that reported sales expansion currently depends on acquisitions and currency rather than broad-based underlying demand. This limits the durability of top-line growth and leaves Essity reliant on successful integration, pricing and recovery in weaker categories.
Input Cost And Margin Pressure
Higher raw material, energy and distribution costs have already reduced gross and group margins, while management expects further COGS pressure. Continued inflation can delay price recovery, constrain profitability and reduce the earnings benefit from savings initiatives.
Uneven Earnings Quality
Volatile net income makes Essity’s earnings power less predictable even though operating margins remain solid. Uneven profitability can complicate capital allocation and weaken confidence that current returns will persist, particularly while restructuring and cost pressures remain elevated.
Essity AB News
ESWB FAQ
What was Essity AB’s price range in the past 12 months?
What is Essity AB’s market cap?
When is Essity AB’s upcoming earnings report date?
How were Essity AB’s earnings last quarter?
Is Essity AB overvalued?
Does Essity AB pay dividends?
What is Essity AB’s EPS estimate?
How many shares outstanding does Essity AB have?
What happened to Essity AB’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Essity AB?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Essity AB
Essity AB (publ) is a global manufacturer and distributor of personal care and wellness goods, along with related services. Its portfolio encompasses medical and healthcare items such as incontinence management solutions, wound care treatments, compression wear, orthopedic supports, skincare formulations, and advanced digital health tools featuring sensor technology. The company organizes its business into several divisions: Personal Care, Consumer Tissue, Professional Hygiene, and various other operations. Essity also manufactures a wide array of consumer products, including absorbent items (pads, diapers, washable absorbent underwear, menstrual cups, incontinence products), personal care items (wet wipes, skincare, intimate soaps), and paper goods (toilet papers, household towels, handkerchiefs, facial tissues, napkins). For professional settings, its hygiene offerings include restroom essentials (toilet papers, paper hand towels, napkins), hand care (soaps, lotions, sanitizers), dispensing systems, and cleaning/wiping solutions. Furthermore, the firm delivers digital innovations, particularly Internet of Things (IoT) sensor technology designed for data-driven facility management, alongside associated service and maintenance. These solutions cater to a diverse clientele, including corporate offices, educational institutions, healthcare providers, industrial sites, food service establishments, hospitality venues, sports arenas, and various other public spaces. Its medical and healthcare product lines, sold under brand names such as TENA, Leukoplast, Cutimed, JOBST, Actimove, and Delta-Cast, reach consumers through a variety of channels, including pharmacies, specialized medical device retailers, hospitals, authorized distributors, care facilities, and online platforms. Consumer products, featuring brands like Libero, Libresse, Nosotras, Saba, TOM Organic, Lotus, Regio, Tempo, and Vinda, are available via retail outlets and e-commerce. Professional hygiene items, branded as TORK, are distributed through intermediaries and digital storefronts. Essity's market presence extends across Europe, North America, Latin America, Asia, and other international regions. Established in 1849, Essity AB (publ) maintains its headquarters in Stockholm, Sweden.
- Sector
- Consumerdefensive
- Industry
- Household & Personal Products
- CEO
- Ulrika Kolsrud
- Employees
- 36,000
- Website
- www.essity.com
- Address
- Klarabergsviadukten 63, Stockholm, AB, 101 23, SE
Essity AB (ESWB) Earnings & Revenues
ESWB Company Deck
ESWB Earnings Call
Earnings Call SentimentNeutral
The call presented a resilient but mixed quarter. Positive elements included stable group volumes, reported sales growth, market-share gains in Personal Care, progress in Feminine Care acquisitions, strong cash flow, a strong balance sheet, cost-saving execution and continued innovation. These were offset by negative organic sales growth, declines in Consumer Tissue, Baby Care and total Professional Hygiene volumes, substantial COGS inflation, margin contraction, elevated restructuring charges and expectations for further Q4 cost increases. Overall, the positive operational and strategic progress was balanced by significant cost and market pressures.
View all DE:ESWB earnings summariesESWB Net sales Breakdown
- 54.31% Consumer Goods
- 26.83% Professional Hygiene
- 18.84% Health & Medical
- 0.02% Other
ESWB Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 15 | 3 | 4 |
| Technical Analysis | 3 | 3 | 4 |
| Moving Averages | 12 | 0 | 0 |
